Loading...
LifeTech Scientific Corporation
LFTSF•PNK
Healthcare
Medical - Devices
$0.23
$0.00(0.00%)

Over the past four quarters, LifeTech Scientific Corporation demonstrated steady revenue growth, increasing from $319.75M in Q2 2023 to $652.83M in Q2 2024. Operating income reached $202.006M in Q2 2024, maintaining a consistent 31% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $208.48M, reflecting operational efficiency. Net income rose to $205.56M, with EPS at $0.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan